Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
Infect-ERA is an ERA-NET on human infectious diseases funded under the Seventh Research Framework Programme .
Infect-ERA will support scientific research involving all basic aspects of human infection biology caused by bacteria, fungi, viruses and protozoa. More precisely, research addressing the cross-talk between host and pathogens, as well as the relationship between microbes’ environment and infection are in the scope of Infect-ERA.
Característiques principals
With this fourth call, Infect-ERA aims to fund transnational and translational research, bringing together basic, applied and technology-driven research approaches of a broad variety of research topics regarding human infectious diseases (ID). This call enables multinational, collaborative research projects that address a specific topic of human ID research.

There are two main research topics, which are equal in relevance for this call:
  • The host-pathogen interactions, with regard to clinically relevant microbial clones, focused on host susceptibility (e.g., innate immune response, populations at risk, etc.).
  • Development of innovative strategies for the diagnostic and treatment of high clinically relevant microbial infections; optimisation of antimicrobial therapy in an individual patient and development of biomarkers to allow individual response prediction.

    To address the above two topics the proposals could contemplate:
  • Identification of host factors that define host susceptibility in regards to infection, disease progression and transmissibility.
  • Differences in susceptibility to infections between individuals or inadequate response to infections and/or treatments.
  • Host molecular mechanisms that define the competence of the pathogen.
  • Development of innovative strategies for the diagnostic and treatment of microbial infections for personalised treatments.
  • Identification of biomarkers based on the host-pathogen interaction that allow individual response prediction to shorten antimicrobial treatment courses.
  • Identification of rare mutations associated with host susceptibility.
  • Individual differences in response to vaccination.
  • Development of innovative antimicrobial strategies focused on exploiting the host immune response.
  • Development of new methods for rapid determination of drug levels and/or microbial burden, at different body sites and in different bodily fluids, to optimize antimicrobial therapy in an individual patient.

    Proposals with topics HIV/AIDS, malaria and tuberculosis are not in the scope of the call.

    The proposals should favourably a) show a close cooperation between academic and clinical and/or industrial participants, b) convincingly present the applications (exploitations) of the project results, and c) demonstrate a clear benefit to the public.

    The following countries are involved: Austria, Belgium, France, Germany, Hungary, India, Israel, Italy, Poland, Portugal, Romania and Spain.
    • Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76.
    Marta López: mlopez4@imim.es Ext.: 1576
    Carol Barnwell: cbarnwell@imim.es Ext.1670
    Convocatòria (URL)
    http://www.infect-era.eu/4th-call-2016
    Online submission platform:
    https://www.submission-infect-era.eu/
    Requisits
    Only transnational projects will be funded. Each collaborative consortium should have the optimal critical mass to achieve ambitious scientific goals and should clearly show an added value from working together.

    Each consortium submitting a proposal must involve:
  • a maximum of six partners, however, applicants are encouraged to include partners funded by the following funding organisation: ANCSI (Romania), IWT-Flanders (Belgium), NCBR (Poland), NCN (Poland) and NKIH (Hungary). If such partners are included into the consortium, the maximum number of partners can be increased up to seven
  • a maximum of two partners per country
  • a minimum of three partners, which must be eligible for the funding organisations of three different countries participating in this call

    Non-funded project partners may also be part of the consortia if they are able to clearly demonstrate an added value to the consortium and secure their own funding. However, the coordinator and the majority of partners in a consortium must be eligible for the funding organisations participating in this call. If one of the partners is not eligible the proposal will be rejected without further review.

    Each consortium should favourably include participants from both academia and clinics or industry (please note the national regulations).

    Applicants must refer and adhere to the specific regulations of the national funding organisations. Each project partner is responsible for ensuring that he/she meets the national eligibility criteria. Therefore each project partner is strongly encouraged to get in touch with his/her National Contact. The National Regulations of each partner country are described in the Guidelines for Applicants. Young scientists - Part of the available funding is dedicated especially to consortia of young scientists. Please check the Guidelines for Applicants for eligibility requirements.

    		•
    Dotació
    For Spanish participants (ISCIII):
  • € 100.000 for Project partners
  • € 150.000 for Project coordinators
  • Maximum funding per project: € 200.000
    • Durada
    3 years.

    Arxius

    Arxiu
    Call text
    Guidelines